Selected research
Industry Research
Endocrine Therapy Medication Industry Research Report 2026
Market perspective
The global Endocrine Therapy Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Endocrine Therapy Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Endocrine Therapy Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Endocrine Therapy Medication include Chongqing Laimi Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd. and Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Endocrine Therapy Medication market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Endocrine Therapy Medication Market by Company
Chongqing Laimi Pharmaceutical Co., Ltd.
Zhongpeptide Biochemical Co., Ltd.
Zhejiang Haizhou Pharmaceutical Co., Ltd.
Zhejiang Haizheng Pharmaceutical Co., Ltd.
Changchun Jinsai Pharmaceutical Co., Ltd.
Yangtze River Pharmaceutical Group Co., Ltd.
Shenzhen Hanyu Pharmaceutical Co., Ltd.
Shanghai Lizhu Pharmaceutical Co., Ltd.
Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
Shanghai Zhaohui Pharmaceutical Co., Ltd.
Maanshan Fengyuan Pharmaceutical Co., Ltd.
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Good Doctor Pharmaceutical Group Co., Ltd.
Dandong Yichuang Pharmaceutical Co., Ltd.
Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Beijing Bornte Pharmaceutical Co., Ltd.
Teva
Pfizer
Janssen Biotech
Eli Lilly and Company
Dr. Reddy's
Cougar Biotechnology, Inc.
AstraZeneca
Endocrine Therapy Medication Segment by Type
Hormones and Related Drugs
Hormone Antagonists and Related Drugs
Endocrine Therapy Medication Segment by Application
Hospital
Clinic
Other
Endocrine Therapy Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Endocrine Therapy Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Endocrine Therapy Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Endocrine Therapy Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Endocrine Therapy Medication Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Endocrine Therapy Medication Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Endocrine Therapy Medication Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Endocrine Therapy Medication Revenue of Manufacturers (2021-2026)
Table 9. Global Endocrine Therapy Medication Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Endocrine Therapy Medication Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Endocrine Therapy Medication Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Endocrine Therapy Medication, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Endocrine Therapy Medication, Product Type & Application
Table 14. Global Endocrine Therapy Medication Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Endocrine Therapy Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
Table 19. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
Table 20. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 22. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
Table 23. Zhongpeptide Biochemical Co., Ltd. Company Information
Table 24. Zhongpeptide Biochemical Co., Ltd. Business Overview
Table 25. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 27. Zhongpeptide Biochemical Co., Ltd. Recent Developments
Table 28. Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
Table 29. Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview
Table 30. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 32. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments
Table 33. Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
Table 34. Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview
Table 35. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 37. Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments
Table 38. Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
Table 39. Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview
Table 40. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 42. Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments
Table 43. Yangtze River Pharmaceutical Group Co., Ltd. Company Information
Table 44. Yangtze River Pharmaceutical Group Co., Ltd. Business Overview
Table 45. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 47. Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments
Table 48. Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
Table 49. Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview
Table 50. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 52. Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments
Table 53. Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
Table 54. Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview
Table 55. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 57. Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments
Table 58. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
Table 59. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview
Table 60. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 62. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments
Table 63. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
Table 64. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
Table 65. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 67. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
Table 68. Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
Table 69. Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview
Table 70. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 72. Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments
Table 73. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
Table 74. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
Table 75. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 77. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
Table 78. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
Table 79. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
Table 80. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 82. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments
Table 83. Good Doctor Pharmaceutical Group Co., Ltd. Company Information
Table 84. Good Doctor Pharmaceutical Group Co., Ltd. Business Overview
Table 85. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 87. Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments
Table 88. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
Table 89. Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
Table 90. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 92. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
Table 93. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
Table 94. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
Table 95. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 97. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
Table 98. Beijing Bornte Pharmaceutical Co., Ltd. Company Information
Table 99. Beijing Bornte Pharmaceutical Co., Ltd. Business Overview
Table 100. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 102. Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments
Table 103. Teva Company Information
Table 104. Teva Business Overview
Table 105. Teva Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Teva Endocrine Therapy Medication Product Portfolio
Table 107. Teva Recent Developments
Table 108. Pfizer Company Information
Table 109. Pfizer Business Overview
Table 110. Pfizer Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Pfizer Endocrine Therapy Medication Product Portfolio
Table 112. Pfizer Recent Developments
Table 113. Janssen Biotech Company Information
Table 114. Janssen Biotech Business Overview
Table 115. Janssen Biotech Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Janssen Biotech Endocrine Therapy Medication Product Portfolio
Table 117. Janssen Biotech Recent Developments
Table 118. Eli Lilly and Company Company Information
Table 119. Eli Lilly and Company Business Overview
Table 120. Eli Lilly and Company Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
Table 122. Eli Lilly and Company Recent Developments
Table 123. Dr. Reddy's Company Information
Table 124. Dr. Reddy's Business Overview
Table 125. Dr. Reddy's Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Dr. Reddy's Endocrine Therapy Medication Product Portfolio
Table 127. Dr. Reddy's Recent Developments
Table 128. Cougar Biotechnology, Inc. Company Information
Table 129. Cougar Biotechnology, Inc. Business Overview
Table 130. Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
Table 132. Cougar Biotechnology, Inc. Recent Developments
Table 133. AstraZeneca Company Information
Table 134. AstraZeneca Business Overview
Table 135. AstraZeneca Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. AstraZeneca Endocrine Therapy Medication Product Portfolio
Table 137. AstraZeneca Recent Developments
Table 138. Global Endocrine Therapy Medication Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 139. Global Endocrine Therapy Medication Sales by Region (2021-2026) & (K Units)
Table 140. Global Endocrine Therapy Medication Sales Market Share by Region (2021-2026)
Table 141. Global Endocrine Therapy Medication Sales by Region (2027-2032) & (K Units)
Table 142. Global Endocrine Therapy Medication Sales Market Share by Region (2027-2032)
Table 143. Global Endocrine Therapy Medication Revenue by Region (2021-2026) & (US$ Million)
Table 144. Global Endocrine Therapy Medication Revenue Market Share by Region (2021-2026)
Table 145. Global Endocrine Therapy Medication Revenue by Region (2027-2032) & (US$ Million)
Table 146. Global Endocrine Therapy Medication Revenue Market Share by Region (2027-2032)
Table 147. North America Endocrine Therapy Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. North America Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 149. North America Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 150. North America Endocrine Therapy Medication Revenue by Country (2021-2026) & (US$ Million)
Table 151. North America Endocrine Therapy Medication Revenue by Country (2027-2032) & (US$ Million)
Table 152. Europe Endocrine Therapy Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Europe Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 154. Europe Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 155. Europe Endocrine Therapy Medication Revenue by Country (2021-2026) & (US$ Million)
Table 156. Europe Endocrine Therapy Medication Revenue by Country (2027-2032) & (US$ Million)
Table 157. Asia Pacific Endocrine Therapy Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. Asia Pacific Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 159. Asia Pacific Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 160. Asia Pacific Endocrine Therapy Medication Revenue by Country (2021-2026) & (US$ Million)
Table 161. Asia Pacific Endocrine Therapy Medication Revenue by Country (2027-2032) & (US$ Million)
Table 162. South America Endocrine Therapy Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. South America Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 164. South America Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 165. South America Endocrine Therapy Medication Revenue by Country (2021-2026) & (US$ Million)
Table 166. South America Endocrine Therapy Medication Revenue by Country (2027-2032) & (US$ Million)
Table 167. Middle East and Africa Endocrine Therapy Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 168. Middle East and Africa Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 169. Middle East and Africa Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 170. Middle East and Africa Endocrine Therapy Medication Revenue by Country (2021-2026) & (US$ Million)
Table 171. Middle East and Africa Endocrine Therapy Medication Revenue by Country (2027-2032) & (US$ Million)
Table 172. Global Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units)
Table 173. Global Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units)
Table 174. Global Endocrine Therapy Medication Sales Market Share by Type (2021-2026)
Table 175. Global Endocrine Therapy Medication Sales Market Share by Type (2027-2032)
Table 176. Global Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million)
Table 177. Global Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million)
Table 178. Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2026)
Table 179. Global Endocrine Therapy Medication Revenue Market Share by Type (2027-2032)
Table 180. Global Endocrine Therapy Medication Price by Type (2021-2026) & (US$/Unit)
Table 181. Global Endocrine Therapy Medication Price by Type (2027-2032) & (US$/Unit)
Table 182. Global Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units)
Table 183. Global Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units)
Table 184. Global Endocrine Therapy Medication Sales Market Share by Application (2021-2026)
Table 185. Global Endocrine Therapy Medication Sales Market Share by Application (2027-2032)
Table 186. Global Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million)
Table 187. Global Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million)
Table 188. Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2026)
Table 189. Global Endocrine Therapy Medication Revenue Market Share by Application (2027-2032)
Table 190. Global Endocrine Therapy Medication Price by Application (2021-2026) & (US$/Unit)
Table 191. Global Endocrine Therapy Medication Price by Application (2027-2032) & (US$/Unit)
Table 192. Key Raw Materials
Table 193. Raw Materials Key Suppliers
Table 194. Endocrine Therapy Medication Distributors List
Table 195. Endocrine Therapy Medication Customers List
Table 196. Endocrine Therapy Medication Industry Trends
Table 197. Endocrine Therapy Medication Industry Drivers
Table 198. Endocrine Therapy Medication Industry Restraints
Table 199. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Endocrine Therapy Medication Product Image
Figure 5. Global Endocrine Therapy Medication Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Endocrine Therapy Medication Market Size (2021-2032) & (US$ Million)
Figure 7. Global Endocrine Therapy Medication Sales (2021-2032) & (K Units)
Figure 8. Global Endocrine Therapy Medication Average Price (US$/Unit) & (2021-2032)
Figure 9. Hormones and Related Drugs Product Image
Figure 10. Hormone Antagonists and Related Drugs Product Image
Figure 11. Hospital Product Image
Figure 12. Clinic Product Image
Figure 13. Other Product Image
Figure 14. Global Endocrine Therapy Medication Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Endocrine Therapy Medication, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Endocrine Therapy Medication Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Endocrine Therapy Medication Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Endocrine Therapy Medication Sales by Region in 2025
Figure 20. Global Endocrine Therapy Medication Revenue by Region in 2025
Figure 21. North America Endocrine Therapy Medication Market Size by Country in 2025
Figure 22. North America Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 23. North America Endocrine Therapy Medication Revenue Market Share by Country (2021-2032)
Figure 24. United States Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Endocrine Therapy Medication Market Size by Country in 2025
Figure 28. Europe Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 29. Europe Endocrine Therapy Medication Revenue Market Share by Country (2021-2032)
Figure 30. Germany Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Endocrine Therapy Medication Market Size by Country in 2025
Figure 41. Asia Pacific Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Endocrine Therapy Medication Revenue Market Share by Country (2021-2032)
Figure 43. China Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Endocrine Therapy Medication Market Size by Country in 2025
Figure 52. South America Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 53. South America Endocrine Therapy Medication Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Endocrine Therapy Medication Market Size by Country in 2025
Figure 58. Middle East and Africa Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Endocrine Therapy Medication Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Endocrine Therapy Medication Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Endocrine Therapy Medication Sales Market Share by Type (2021-2032)
Figure 66. Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2032)
Figure 67. Global Endocrine Therapy Medication Price (US$/Unit) by Type (2021-2032)
Figure 68. Global Endocrine Therapy Medication Sales Market Share by Application (2021-2032)
Figure 69. Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2032)
Figure 70. Global Endocrine Therapy Medication Price (US$/Unit) by Application (2021-2032)
Figure 71. Endocrine Therapy Medication Value Chain
Figure 72. Endocrine Therapy Medication Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Endocrine Therapy Medication Industry Opportunities and Challenges
Scope & coverage.
Types
- Hormones and Related Drugs
- Hormone Antagonists and Related Drugs
Applications
- Hospital
- Clinic
- Other
Companies covered
- Chongqing Laimi Pharmaceutical Co., Ltd.
- Zhongpeptide Biochemical Co., Ltd.
- Zhejiang Haizhou Pharmaceutical Co., Ltd.
- Zhejiang Haizheng Pharmaceutical Co., Ltd.
- Changchun Jinsai Pharmaceutical Co., Ltd.
- Yangtze River Pharmaceutical Group Co., Ltd.
- Shenzhen Hanyu Pharmaceutical Co., Ltd.
- Shanghai Lizhu Pharmaceutical Co., Ltd.
- Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
- Shanghai Zhaohui Pharmaceutical Co., Ltd.
- Maanshan Fengyuan Pharmaceutical Co., Ltd.
- Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Good Doctor Pharmaceutical Group Co., Ltd.
- Dandong Yichuang Pharmaceutical Co., Ltd.
- Chengdu Tiantaishan Pharmaceutical Co., Ltd.
- Beijing Bornte Pharmaceutical Co., Ltd.
- Teva
- Pfizer
- Janssen Biotech
- Eli Lilly and Company
- Dr. Reddy's
- Cougar Biotechnology, Inc.
- AstraZeneca
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Endocrine Therapy Medication Market Size (2021-2032)
- 2.2.2 Global Endocrine Therapy Medication Sales (2021-2032)
- 2.2.3 Global Endocrine Therapy Medication Market Average Price (2021-2032)
- 2.3 Endocrine Therapy Medication by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hormones and Related Drugs
- 2.3.3 Hormone Antagonists and Related Drugs
- 2.4 Endocrine Therapy Medication by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Endocrine Therapy Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Endocrine Therapy Medication Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Endocrine Therapy Medication Revenue of Manufacturers (2021-2026)
- 3.4 Global Endocrine Therapy Medication Average Price by Manufacturers (2021-2026)
- 3.5 Global Endocrine Therapy Medication Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Endocrine Therapy Medication, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Endocrine Therapy Medication, Product Type & Application
- 3.8 Global Manufacturers of Endocrine Therapy Medication, Established Date
- 3.9 Global Endocrine Therapy Medication Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chongqing Laimi Pharmaceutical Co., Ltd.
- 4.1.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.1.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Zhongpeptide Biochemical Co., Ltd.
- 4.2.1 Zhongpeptide Biochemical Co., Ltd. Company Information
- 4.2.2 Zhongpeptide Biochemical Co., Ltd. Business Overview
- 4.2.3 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.2.5 Zhongpeptide Biochemical Co., Ltd. Recent Developments
- 4.3 Zhejiang Haizhou Pharmaceutical Co., Ltd.
- 4.3.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.3.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Zhejiang Haizheng Pharmaceutical Co., Ltd.
- 4.4.1 Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.4.5 Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Changchun Jinsai Pharmaceutical Co., Ltd.
- 4.5.1 Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.5.5 Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Yangtze River Pharmaceutical Group Co., Ltd.
- 4.6.1 Yangtze River Pharmaceutical Group Co., Ltd. Company Information
- 4.6.2 Yangtze River Pharmaceutical Group Co., Ltd. Business Overview
- 4.6.3 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.6.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments
- 4.7 Shenzhen Hanyu Pharmaceutical Co., Ltd.
- 4.7.1 Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.7.5 Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Shanghai Lizhu Pharmaceutical Co., Ltd.
- 4.8.1 Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.8.5 Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
- 4.9.1 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.9.5 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Shanghai Zhaohui Pharmaceutical Co., Ltd.
- 4.10.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.10.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
- 4.11 Maanshan Fengyuan Pharmaceutical Co., Ltd.
- 4.11.1 Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
- 4.11.2 Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview
- 4.11.3 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.11.5 Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments
- 4.12 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
- 4.12.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
- 4.12.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
- 4.12.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.12.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
- 4.13 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- 4.13.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
- 4.13.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
- 4.13.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.13.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments
- 4.14 Good Doctor Pharmaceutical Group Co., Ltd.
- 4.14.1 Good Doctor Pharmaceutical Group Co., Ltd. Company Information
- 4.14.2 Good Doctor Pharmaceutical Group Co., Ltd. Business Overview
- 4.14.3 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.14.5 Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments
- 4.15 Dandong Yichuang Pharmaceutical Co., Ltd.
- 4.15.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
- 4.15.2 Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
- 4.15.3 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.15.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
- 4.16 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
- 4.16.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
- 4.16.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
- 4.16.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.16.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
- 4.17 Beijing Bornte Pharmaceutical Co., Ltd.
- 4.17.1 Beijing Bornte Pharmaceutical Co., Ltd. Company Information
- 4.17.2 Beijing Bornte Pharmaceutical Co., Ltd. Business Overview
- 4.17.3 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 4.17.5 Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments
- 4.18 Teva
- 4.18.1 Teva Company Information
- 4.18.2 Teva Business Overview
- 4.18.3 Teva Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Teva Endocrine Therapy Medication Product Portfolio
- 4.18.5 Teva Recent Developments
- 4.19 Pfizer
- 4.19.1 Pfizer Company Information
- 4.19.2 Pfizer Business Overview
- 4.19.3 Pfizer Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Pfizer Endocrine Therapy Medication Product Portfolio
- 4.19.5 Pfizer Recent Developments
- 4.20 Janssen Biotech
- 4.20.1 Janssen Biotech Company Information
- 4.20.2 Janssen Biotech Business Overview
- 4.20.3 Janssen Biotech Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Janssen Biotech Endocrine Therapy Medication Product Portfolio
- 4.20.5 Janssen Biotech Recent Developments
- 4.21 Eli Lilly and Company
- 4.21.1 Eli Lilly and Company Company Information
- 4.21.2 Eli Lilly and Company Business Overview
- 4.21.3 Eli Lilly and Company Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
- 4.21.5 Eli Lilly and Company Recent Developments
- 4.22 Dr. Reddy's
- 4.22.1 Dr. Reddy's Company Information
- 4.22.2 Dr. Reddy's Business Overview
- 4.22.3 Dr. Reddy's Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Dr. Reddy's Endocrine Therapy Medication Product Portfolio
- 4.22.5 Dr. Reddy's Recent Developments
- 4.23 Cougar Biotechnology, Inc.
- 4.23.1 Cougar Biotechnology, Inc. Company Information
- 4.23.2 Cougar Biotechnology, Inc. Business Overview
- 4.23.3 Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
- 4.23.5 Cougar Biotechnology, Inc. Recent Developments
- 4.24 AstraZeneca
- 4.24.1 AstraZeneca Company Information
- 4.24.2 AstraZeneca Business Overview
- 4.24.3 AstraZeneca Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 AstraZeneca Endocrine Therapy Medication Product Portfolio
- 4.24.5 AstraZeneca Recent Developments
5 Global Endocrine Therapy Medication Market Scenario by Region
- 5.1 Global Endocrine Therapy Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Endocrine Therapy Medication Sales by Region: 2021-2032
- 5.2.1 Global Endocrine Therapy Medication Sales by Region: 2021-2026
- 5.2.2 Global Endocrine Therapy Medication Sales by Region: 2027-2032
- 5.3 Global Endocrine Therapy Medication Revenue by Region: 2021-2032
- 5.3.1 Global Endocrine Therapy Medication Revenue by Region: 2021-2026
- 5.3.2 Global Endocrine Therapy Medication Revenue by Region: 2027-2032
- 5.4 North America Endocrine Therapy Medication Market Facts & Figures by Country
- 5.4.1 North America Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Endocrine Therapy Medication Sales by Country (2021-2032)
- 5.4.3 North America Endocrine Therapy Medication Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Endocrine Therapy Medication Market Facts & Figures by Country
- 5.5.1 Europe Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Endocrine Therapy Medication Sales by Country (2021-2032)
- 5.5.3 Europe Endocrine Therapy Medication Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Endocrine Therapy Medication Market Facts & Figures by Country
- 5.6.1 Asia Pacific Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Endocrine Therapy Medication Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Endocrine Therapy Medication Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Endocrine Therapy Medication Market Facts & Figures by Country
- 5.7.1 South America Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Endocrine Therapy Medication Sales by Country (2021-2032)
- 5.7.3 South America Endocrine Therapy Medication Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Endocrine Therapy Medication Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Endocrine Therapy Medication Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Endocrine Therapy Medication Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Endocrine Therapy Medication Sales by Type (2021-2032)
- 6.1.1 Global Endocrine Therapy Medication Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Endocrine Therapy Medication Sales Market Share by Type (2021-2032)
- 6.2 Global Endocrine Therapy Medication Revenue by Type (2021-2032)
- 6.2.1 Global Endocrine Therapy Medication Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2032)
- 6.3 Global Endocrine Therapy Medication Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Endocrine Therapy Medication Sales by Application (2021-2032)
- 7.1.1 Global Endocrine Therapy Medication Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Endocrine Therapy Medication Sales Market Share by Application (2021-2032)
- 7.2 Global Endocrine Therapy Medication Revenue by Application (2021-2032)
- 7.2.1 Global Endocrine Therapy Medication Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2032)
- 7.3 Global Endocrine Therapy Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Endocrine Therapy Medication Value Chain Analysis
- 8.1.1 Endocrine Therapy Medication Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Endocrine Therapy Medication Production Mode & Process
- 8.2 Endocrine Therapy Medication Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Endocrine Therapy Medication Distributors
- 8.2.3 Endocrine Therapy Medication Customers
9 Global Endocrine Therapy Medication Analyzing Market Dynamics
- 9.1 Endocrine Therapy Medication Industry Trends
- 9.2 Endocrine Therapy Medication Industry Drivers
- 9.3 Endocrine Therapy Medication Industry Opportunities and Challenges
- 9.4 Endocrine Therapy Medication Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst